Indian Pharma Gets Relief from Trump’s Tariffs
Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices in the US domestic market for patients, who are already dealing with drug shortages. IMAGE: Kindly note the image has